Plasma thrombin-activatable fibrinolysis inhibitor as an indicator of inflammation and disease severity in acute pancreatitis


Sayilir A., Beyazit Y., YEŞİL Y. , Albayrak M., Ekiz F., Celik T., ...More

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, vol.36, no.5, pp.498-504, 2012 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 36 Issue: 5
  • Publication Date: 2012
  • Doi Number: 10.1016/j.clinre.2011.12.006
  • Title of Journal : CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY
  • Page Numbers: pp.498-504

Abstract

Aim: In addition to suppressing fibrinolysis, thrombin activatable fibrinolysis inhibitor (TAFI) was suggested to be involved in inflammation. To date, no study has been published that reports the role of TAFI in acute pancreatitis (AP). Therefore, the objective of the present study was to investigate the role of plasma TAFI as an indicator of inflammation in AP, and its association with disease severity.